CYP2C19 Genotype and Cardiovascular Events Reply

被引：1
|
作者：
Nissen, Steven E. [1 ]
机构：
[1] Cleveland Clin Fdn, Div Cardiovasc Med, Cleveland, OH 44195 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 307卷 / 14期
关键词：
RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; ESTROGEN; RISK;
D O I：
10.1001/jama.2012.447
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1485 / 1485
页数：1
相关论文
共 50 条
  • [41] The Genotype Frequency of CYP2C19 Enzyme after Liver Transplantation
    Badiee, P.
    Hashemizadeh, Z.
    Malek-Hosseini, S. A.
    Geramizadeh, B.
    INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2019, 10 (02):
  • [42] Modulation of CYP2C19 activity and genotype in patients with hepatic carcinoma
    Kurata, N
    Nishimura, Y
    Iwase, M
    Yasuhara, H
    DRUG METABOLISM REVIEWS, 2004, 36 : 112 - 112
  • [43] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Daniele Jones
    Shana Persad-Ramdeensingh
    Sheherazade Crystal Abrahim
    Naveen Seecheran
    Rajini Rani Haraksingh
    Cardiology and Therapy, 2024, 13 : 191 - 203
  • [44] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Jones, Daniele
    Persad-Ramdeensingh, Shana
    Abrahim, Sheherazade Crystal
    Seecheran, Naveen
    Haraksingh, Rajini Rani
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 191 - 203
  • [45] Association between blood carisoprodol:: meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers:: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
    Bramness, JG
    Skurtveit, S
    Fauske, L
    Grung, M
    Molven, A
    Morland, J
    Steen, VM
    PHARMACOGENETICS, 2003, 13 (07): : 383 - 388
  • [46] Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
    Kim, K. -A.
    Song, W. -K.
    Kim, K. -R.
    Park, J. -Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 697 - 703
  • [47] Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
    Mega, Jessica L.
    Hochholzer, Willibald
    Frelinger, Andrew L., III
    Kluk, Michael J.
    Angiolillo, Dominick J.
    Kereiakes, Dean J.
    Isserman, Steven
    Rogers, William J.
    Ruff, Christian T.
    Contant, Charles
    Pencina, Michael J.
    Scirica, Benjamin M.
    Longtine, Janina A.
    Michelson, Alan D.
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (20): : 2221 - 2228
  • [48] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Zalloum, Imad
    Hakooz, Nancy
    Arafat, Tawfiq
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4195 - 4200
  • [49] Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs
    Katsuyoshi Sugimoto
    Tsukasa Uno
    Tomonori Tateishi
    European Journal of Clinical Pharmacology, 2008, 64 : 583 - 587
  • [50] The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19☆2 genotyping
    Langaee, Taimour Y.
    Zhu, Hao-Jie
    Wang, Xinwen
    El Rouby, Nihal
    Markowitz, John S.
    Goldstein, Joyce A.
    Johnson, Julie A.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (08): : 381 - 386
12345